MetaCap

Sutro Biopharma Earnings

NASDAQ: STROHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

14.66+0.21 (+1.45%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 14.66 0.00%

Next earnings date

Thu, Nov 5, 2026

Fiscal period

Sep/2026

EPS estimate

$-1.88

Sutro Biopharma earnings summary

Sutro Biopharma is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.88.

Summary generated from market data by MetaCap's automated system. Methodology

Related